Accessibility Menu
Cyteir Therapeutics logo

Cyteir Therapeutics

(NASDAQ) CYT

Current PriceN/A
Market CapN/A
Since IPO (2021)-83%
5 YearN/A
1 Year+48%
1 Month-0%

Cyteir Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$30.88M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

CYT News

No articles available.

CYT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cyteir Therapeutics

Industry

Pharmaceuticals

Headquarters

Lexington, MA 02421, US

CYT Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-26%

Return on Capital

-33%

Return on Assets

-29%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.38M

Operating Income

$48.17M

EBITDA

$46.06M

Operating Cash Flow

$42.53M

Capital Expenditure

$312.00K

Free Cash Flow

$42.84M

Cash & ST Invst.

$147.12M

Total Debt

$889.00K

Cyteir Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$100.00K

+50.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

46

N/A

Net Income

$3.53M

+65.8%

EBITDA

$5.06M

+56.3%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Net Cash

$129.23M

-15.5%

Accounts Receivable

$0.00

N/A

Inventory

$17.00K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$16.00K

-98.2%

Return on Assets

-28.68%

N/A

Return on Invested Capital

-32.57%

N/A

Free Cash Flow

$4.56M

+63.8%

Operating Cash Flow

$4.56M

+63.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OPNTOpiant Pharmaceuticals, Inc.
$20.65+0.00%
RVLPRVL Pharmaceuticals plc
$0.03-32.05%
HLVXHilleVax, Inc.
$2.09-0.48%
JNCEJounce Therapeutics, Inc.
$1.88+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.35+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%
QQQInvesco QQQ Trust
$593.02-0.00%

Questions About CYT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.